Olopatadine HCL 0.1% Ophthalmic Solution
Award NoticeModification SPE2D223D0007 P00013 No-Cost Settlement Termination for Convenience. Modification SPE2D223D0007 P00012 is issued to incorporate clause 52.222-90, Addressing DEI Discrimination by Federal Contractors (DEVIATION 2026-O0040, REVIS